Review Article - (2012) Volume 0, Issue 0

Patient-specific Induced Pluripotent Stem Cells as a Platform for Disease Modeling, Drug Discovery and Precision Personalized Medicine

Wilson Young1, Sunita L. D’Souza2,4, Ihor R. Lemischka2,3,4 and Christoph Schaniel2,4*
1Department of Medicine, Division of Cardiology, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com
2Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com
3Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com
4Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com
*Corresponding Author: